Clinical Trials in Taipei, Taipei
8 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Genmab496 enrolled75 locationsNCT05283720
Recruiting
Phase 1Phase 2
A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma
Cho Pharma Inc.37 enrolled9 locationsNCT05950165
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.666 enrolled325 locationsNCT06981078
Recruiting
Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Solid Tumors
DualityBio Inc.492 enrolled37 locationsNCT06953089
Recruiting
Phase 1
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Solid Tumor
IDEAYA Biosciences180 enrolled39 locationsNCT04794699
Recruiting
Phase 3
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Soft Tissue Sarcoma
Polaris Group300 enrolled30 locationsNCT05712694